Medical Weight Loss for Philadelphia, Pennsylvania Residents
Philadelphia, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Philadelphia through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Philadelphia Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Philadelphia, Pennsylvania residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Philadelphia is served through telehealth from our Costa Mesa, California clinic. There is no travel, the full physician-supervised program runs by secure video.
For Philadelphia, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout Center City, South Philly, Fishtown, University City, Manayunk, and the greater Philadelphia area. There is no distance surcharge for Philadelphia patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Telehealth removes the distance between Philadelphia and specialized care: your consultation happens wherever you are in Pennsylvania. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Philadelphia patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo · just $7.70/day
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Philadelphia
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Philadelphia address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Philadelphia
Does New Hope Weight Loss treat patients in Philadelphia?
Yes. Although the clinic is in Costa Mesa, California, we treat Philadelphia, Pennsylvania residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Philadelphia?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Philadelphia address in cold-pack packaging.
What do Philadelphia patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Philadelphia do you serve?
We serve patients from across Philadelphia by telehealth, including Center City, South Philly, Fishtown, University City, Manayunk, and the greater Philadelphia area.
What does the program cost for Philadelphia patients?
The same flat, transparent pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month (a 90-day program is $499), and compounded tirzepatide from $233/month. Medication is billed separately. HSA and FSA are accepted.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Philadelphia, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.